Overview

A Phase III of SCRT+CAPOX and SCRT+CAPOXIRI as Preoperative Therapy for Locally Advanced Rectal Cancer (ENSEMBLE)

Status:
Recruiting
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
This trial is a multicenter randomized Phase III study to verify the superiority of short-course preoperative radiation (SCRT) and CAPOXIRI over SCRT and CAPOX as preoperative treatments for locally advanced rectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Center Hospital East
Collaborator:
Japan Agency for Medical Research and Development